Alexander Zinke

Sandy joined Lumeda as Chief Executive Officer to lead the company in its product commercialization and growth phase. A graduate of Harvard Business School (MBA), Mr. Zinke has over 20 years of global healthcare industry experience with innovative companies including Boston Scientific, Cynosure / Hologic, and CDx Diagnostics. Prior to joining Lumeda, he was Vice President of Marketing & Business Development with CDx Diagnostics, known for an advanced diagnostic platform used to preemptively detect cancer based on AI-enabled tissue analysis and 3D imaging. Over the last 10 years, he has led teams that have developed and commercialized more than a dozen products and programs. Sandy has a strong track record of success in building and leading cross-functional teams to drive the global growth of healthcare companies with innovative medical devices and diagnostics products. He brings to Lumeda significant domain expertise and a network of industry contacts to develop key relationships with medical thought leaders and commercial partners critical to accelerating the introduction of the company’s novel PDT technology to the clinic.